Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
This product has not been evaluated by the FDA for safety or effectiveness
Research and legal documents allege that semaglutide, the active ingredient in the popular weight loss drug Wegovy, may cause blindness and vision problems
People who switched from Mounjaro to Foundayo maintained 74.7% of their weight loss, compared to 49.2% on placebo
What You Can Expect At GHCS, every weight management journey is personalized
Observed Mean Plot: eGFR (mL/min/1.73m 2 ) by Week in FLOW Trial How Supplied Single-patient-use pens (with multiple weekly doses): Injection: clear, colorless solution of 0.68 mg/mL, 1.34 mg/mL or 2.68 mg/mL of semaglutide available in the following packaging configurations: Each OZEMPIC multi-dose pen is for use by a single patient
US$ 20.81
US$ 21.74
US$ 22.64
US$ 22.04
US$ 28.38
